Clinical Trial Update: Pixantrone as Bridging Therapy to Allogenic Transplant or CAR-T Cell Therapy in DLBCL Patients

View source ↗

Summary

Clinical trial update indicates pixantrone as bridging therapy to allogeneic transplant or CAR-T cell therapy in patients with diffuse large B-cell lymphoma. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Pixantrone (pixantrone)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Diffuse Large B Cell Lymphoma (DLBCL) | Status: ACTIVE_NOT_RECRUITING